Stock listing
NASDAQ:INBX Inhibrx Inc Stock
Follow Inhibrx Inc into a list and get an email when it puts out news.
Last close · NASDAQ:INBX
$34.35 USD
Close on May 28, 2024 · No longer trades
- Lowest – highest close
- $8.52 – $50.00 USDSince Aug 19, 2020 · lowest Jun 14, 2022 · highest Dec 17, 2020
Delisted NASDAQ:INBX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:INBX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Inhibrx Inc on 6ix
- Decks
- 15 decks · latest November 2023
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 13, 2026 · After close | −6.8% |
| Quarter to Jun 30, 2026 | Aug 13, 2026 · After close | −8.9% |
| Quarter to Mar 31, 2026 | May 14, 2026 · After close | −6.5% |
| Quarter to Dec 31, 2025 | Mar 23, 2026 | +3.6% |
| Quarter to Sep 30, 2025 | Nov 14, 2025 · Before open | +6.0% |
| Quarter to Jun 30, 2025 | Aug 13, 2025 · After close | +1.6% |
| Quarter to Mar 31, 2025 | May 14, 2025 · After close | +10.9% |
| Quarter to Dec 31, 2024 | Mar 17, 2025 | −0.7% |
| Quarter to Sep 30, 2024 | Nov 14, 2024 · After close | −3.5% |
| Quarter to Jun 30, 2024 | Aug 13, 2024 | +0.4% |
All 11 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Mar 31, 2024 | May 29, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Inhibrx Biosciences — Investor Presentation (November 2023) | Investor deck | 37 slides | November 2023 |
| Investor Presentation (August 2023) | Investor deck | 36 slides | Aug 7, 2023 |
| Inhibrx Biosciences — Investor Presentation (May 2023) | Investor deck | 47 slides | May 2023 |
| Investor Presentation (March 2023) | Investor deck | 47 slides | Mar 6, 2023 |
| Investor Presentation (October 2022) | Investor deck | 49 slides | October 2022 |
| Investor Presentation (May 2022) | Investor deck | 44 slides | May 16, 2022 |
| Investor Presentation (April 2022) | Investor deck | 44 slides | Apr 4, 2022 |
| Investor Presentation (January 2022) | Investor deck | 41 slides | Jan 4, 2022 |
| Investor Presentation (October 2021) | Investor deck | 29 slides | October 2021 |
| Inhibrx Biosciences — Investor Presentation (August 2021) | Investor deck | 29 slides | August 2021 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2021) | Investor deck | 29 slides | Jun 21, 2021 |
| Inhibrx Biosciences — Investor Presentation (March 2021) | Investor deck | 33 slides | March 2021 |
| Investor Presentation (January 2021) | Investor deck | 31 slides | Jan 5, 2021 |
| Investor Presentation (November 2020) | Investor deck | 31 slides | Nov 12, 2020 |
| Investor Presentation (September 2020) | Investor deck | 31 slides | Sep 11, 2020 |
Cap table
Built by 6ix from Inhibrx Inc’s releases · as of Aug 7, 2026
- Common shares
- 14,717,660
- Fully diluted
- 14,717,660
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 14,717,660 | Aug 7, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 7, 2026 | 14,717,660 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kimberly Manhard Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past); Ardea Biosciences Inc (SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past) | Director · Aug 18, 2020 – May 30, 2024 · Past |
| Jon Faiz Kayyem Other companies: Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Biodesix, Inc. (Director · Since at least Jan 1, 2024) | Director · May 30, 2024 – May 30, 2024 · Past |
| Brendan P Eckelman Other companies: Inhibrx Biosciences, Inc. (Chief Scientific Officer · May 24, 2024 – May 29, 2024 · Past) | Chief Scientific Officer · Aug 18, 2020 – May 28, 2024 · Past |
| Douglas G. Forsyth Other companies: Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024) | Director · Aug 18, 2020 – May 30, 2024 · Past |
Log in to ask 6ix AI your own questions about Inhibrx Inc.